Literature DB >> 1500198

The integrin-binding domain of invasin is sufficient to allow bacterial entry into mammalian cells.

S Rankin1, R R Isberg, J M Leong.   

Abstract

Yersinia pseudotuberculosis is able to enter normally nonphagocytic host cells by multiple pathways, the most efficient of which is mediated by invasin, a 986-amino-acid bacterial outer membrane protein. It has previously been shown that the C-terminal 192 amino acids of invasin are sufficient to bind mammalian cells. To determine if additional regions of the invasin protein are necessary to promote entry, we developed a novel assay that tests the ability of various invasin derivatives to confer on Staphylococcus aureus the ability to enter animal cells. We determined that the 192-amino-acid cell-binding region of invasin, when used to coat the bacterial cell surface, was also sufficient to promote cellular penetration. These results suggest that the simple binding of invasin to its receptors is sufficient to mediate entry and that the bacterium plays a largely passive role in the entry process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500198      PMCID: PMC257407          DOI: 10.1128/iai.60.9.3909-3912.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells.

Authors:  R R Isberg; J M Leong
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

2.  Hormonal control of apoptosis in hamster uterine luminal epithelium.

Authors:  B A Sandow; N B West; R L Norman; R M Brenner
Journal:  Am J Anat       Date:  1979-09

3.  Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule.

Authors:  M D Pierschbacher; E G Hayman; E Ruoslahti
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

4.  Fibronectin receptor structures in the VLA family of heterodimers.

Authors:  Y Takada; C Huang; M E Hemler
Journal:  Nature       Date:  1987 Apr 9-15       Impact factor: 49.962

5.  Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells.

Authors:  R R Isberg; D L Voorhis; S Falkow
Journal:  Cell       Date:  1987-08-28       Impact factor: 41.582

6.  HeLa cell infection by Yersinia enterocolitica: evidence for lack of intracellular multiplication and development of a new procedure for quantitative expression of infectivity.

Authors:  J A Devenish; D A Schiemann
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

7.  The Yersinia pseudotuberculosis invasin protein and human fibronectin bind to mutually exclusive sites on the alpha 5 beta 1 integrin receptor.

Authors:  G T Van Nhieu; R R Isberg
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

8.  Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein.

Authors:  J M Leong; R S Fournier; R R Isberg
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

9.  The use of lead citrate at high pH as an electron-opaque stain in electron microscopy.

Authors:  E S REYNOLDS
Journal:  J Cell Biol       Date:  1963-04       Impact factor: 10.539

10.  Aldolase exists in both the fluid and solid phases of cytoplasm.

Authors:  L Pagliaro; D L Taylor
Journal:  J Cell Biol       Date:  1988-09       Impact factor: 10.539

View more
  17 in total

1.  A region of the Yersinia pseudotuberculosis invasin protein enhances integrin-mediated uptake into mammalian cells and promotes self-association.

Authors:  P Dersch; R R Isberg
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

2.  Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles.

Authors:  N Hussain; A T Florence
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

3.  Invasion of host cells by Salmonella typhimurium requires focal adhesion kinase and p130Cas.

Authors:  Jing Shi; James E Casanova
Journal:  Mol Biol Cell       Date:  2006-08-16       Impact factor: 4.138

4.  The in vitro cell association of invasin coated polylactide-co-glycolide nanoparticles.

Authors:  G F Dawson; G W Halbert
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

5.  Co-expression of the C-terminal domain of Yersinia enterocolitica invasin enhances the efficacy of classical swine-fever-vectored vaccine based on human adenovirus.

Authors:  Helin Li; Pengbo Ning; Zhi Lin; Wulong Liang; Kai Kang; Lei He; Yanming Zhang
Journal:  J Biosci       Date:  2015-03       Impact factor: 1.826

6.  Proliferation behavior of E. coli in a three-dimensional in vitro tumor model.

Authors:  Nelita Elliott; Tae Lee; Lingchong You; Fan Yuan
Journal:  Integr Biol (Camb)       Date:  2011-05-10       Impact factor: 2.192

7.  Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes.

Authors:  J Katz; V Sambandam; J H Wu; S M Michalek; D F Balkovetz
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  N-glycosylated proteins are involved in efficient internalization of Klebsiella pneumoniae by cultured human epithelial cells.

Authors:  O Fumagalli; B D Tall; C Schipper; T A Oelschlaeger
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

9.  Borrelia burgdorferi BBB07 interaction with integrin alpha3beta1 stimulates production of pro-inflammatory mediators in primary human chondrocytes.

Authors:  Aruna K Behera; Enrique Durand; Carla Cugini; Styliani Antonara; Lori Bourassa; Ethan Hildebrand; Linden T Hu; Jenifer Coburn
Journal:  Cell Microbiol       Date:  2007-09-06       Impact factor: 3.715

10.  Characterization of the C-terminal domains of intimin-like proteins of enteropathogenic and enterohemorrhagic Escherichia coli, Citrobacter freundii, and Hafnia alvei.

Authors:  G Frankel; D C Candy; P Everest; G Dougan
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.